semaglutide age A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Effect of semaglutide 2.4 mg

reuteri possesses the capability to impact the host behavior through vagus nerve 58

US-licensed providers evaluate every prescription individually Studied by our Stanford PhD-led Research Team in the $101M XPRIZE Healthspan competition Rigorously tested for purity and potency by LegitScript-certified pharmacy partners Read our Research AgelessRx researchers are one of 40 global teams competing in the $101M XPRIZE Healthspan competition, studying Glutathione with other therapies to measure real-world impacts reversing brain, muscle, and immune system aging

These changes can shift the makeup of the microbiome

More healthcare awareness, reimbursement systems that look more favorable, and wider access to new treatment options are also pushing growth forward